Warfarin is not appropriate in all patients with AF-associated ischemic stroke
This article has no abstract so we have provided the first paragraph of the full text.
Warfarin considerably reduces the risk of recurrent stroke in patients who have had an ischemic stroke and are in atrial fibrillation (AF). Researchers in New Zealand have investigated the reasons why, despite the proven benefits, only about 50% of patients with AF are started on warfarin therapy following ischemic stroke.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Chemical biology Dressed-up proteinsNature News and Views (26 Apr 2007)
Mathematical physics Added dimensions to grain growthNature News and Views (26 Apr 2007)
Mal-function of TLRs by SOCSNature Immunology News and Views (01 Feb 2006)
Solar size variationNature News and Views (31 Jul 1980)